| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Web Development > Is Content King? |
|
Advice You - Is Content King?
The past night discussion with my colleagues has aroused a keen interest in me to research further to invalidate their argument, not because I disagree with them but I have reasons According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product to disagree. Yes, the outdated argument they have made that content is king. I don’t think so! Please, take some time to read my observation to know the ground reality. There is ab ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in zz all around the corner of the world about the second-generation web, namely web 2.0. What is it? I’m assumed to be an amateur to define web 2.0, for I’m not tech savvy person to k lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. now all the tidbits. As a common person, I use the term in context of interactivity. To my understanding, web 2.0 is a democratic platform to provide equal opportunity for masses in here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe general to ‘voice’ their opinion’. This poses a great threat to ‘elite’ journalists who until yesterday were toying with words to superimpose their opinions for vested interests. Ti d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro me is gone when people like dumb spectators used to believe in their mighty words. Now, people are educated and want to equally participate on the mainstream. Thanks to web 2.0, the ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc much-needed platform has been given. Perhaps, we all know the most recent buzz about citizen journalism/public journalism. As more people become ‘public writers’, there is a fear t easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi hat journalism as a distinct profession is becoming harder and harder to sustain. The boundaries between 'professional' and 'amateur' performance are breaking down. Under these circ nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically mstances, interactivity, not the content, plays a significant role. I, however, don’t deny the importance of content in print media so long as it serves the interest of nation. But and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ the clich? -content is king -is hard nut to crack, at least for me, and the person like me who deem Internet as a powerful medium for 1:1 interaction. If content is King, then why d ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi esn’t it figure in almost a nation’s innovation? If content is supreme, why the national dailies like The Times of India and The Hindustan Time could no be able to preserve the cont ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ents? Why have they gone a step ahead for the commodification of their journalistic instinct? The one simple reason is money. Content doesn’t fetch much money. We all know the reven dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e growth of these papers, which has surprisingly swung up incomparable with the paper like The Hindu. Do you think that ToI’s growth is solely due to creative content? If so, why th cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e very paper has gone ahead to spend money on its presentation, design (color photograph) and marketing? Don’t get me wrong, the content and information architecture components wil tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen always be important to web design. But the truly critical role in a Web 2.0 world will be that of interaction design and search engine marketing. Here, user generated content/user t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel control content plays a significant role. And, the role of online editors/journalists here is to edit their language. Now, they are spectators. If they wish to voice their opinion, ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust owever, they have to join the band of public journalism. It’s not just contents but other factors -offline and online promotions, presentations, etc.-simultaneously work in tandem y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products with each other to reach the audiences. In gist, the importance of content in web 2.0 holds only when it provides an interactive scope for users. Furthermore, the success of any sit . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de in the 2nd generation world depends on the following. 1. The interactive content on the site 2. How the site’s design aids discoverability and findability of that content 3. The elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip site’s aesthetics, usability, look/feel etc. Content is one of the important factors but others things can never be ignored. If a site lacks the above elements, it loses its sheen tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Ethics - Or Code of Ethics (COE), APEX Why Pay Per Action Affiliate Programs Are So Great And How To Profit Wildly From Them!
|